COMP and non-small cell lung carcinoma: A clinical trial to treat NSCLC patients that have a high expression of COMP with these inhibitors, prior to the start of radiation treatment, could be a future direction in order to assess whether these inhibitors would work clinically to reduce radiation resistance in NSCLC.